We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Draft Guidance on Microbiological Contamination After Many Adverse Events and Recalls
FDA Releases Draft Guidance on Microbiological Contamination After Many Adverse Events and Recalls
Due in part to a high number of adverse events and recalls associated with contaminated products, the FDA this week issued a 21-page draft guidance to help manufacturers control microbiological contamination of their nonsterile drugs (NSDs).